$28.36
-1.35-4.54%
最終更新: Oct 14, 12:31 PM
$29.24
-0.47-1.58%
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Hims & Hers Health (HIMS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Hims & Hers Health (HIMS) は、8 10, 2026日にQ3の2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$880M - $900Mの範囲と予想しています。
以前のガイダンスと比較して、Hims & Hers Healthは売上高予測を以前の範囲である引き下げから$3.1B - $3.3Bに引き上げました。
Hims & Hers Healthは、32から11 7, 2022の間に8 10, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 13 times and lowered it 15 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $0.04 | $0.03 | $0.10 |
| Actual | $-0.37 | $-0.40 | $0.08 | $0.09 |
| Surprise | -640.0% | -1100.0% | +166.7% | -10.0% |
| Revenue | ||||
| Estimate | $722.1M | $617.4M | $618.0M | $581.4M |
| Actual | $753.2M | $608.1M | $617.8M | $599.0M |
| Surprise | +4.30% | -1.51% | -0.03% | +3.03% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.06 | $0.11 | $-0.03 | $0.06 |
| Revenue | ||||
| Consensus | $892.9M | $955.9M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.37 | $-0.05 | -640.0 % |
| Q1 | May 11, 2026 | $-0.40 | $0.04 | -1100.0 % |
| Q4 | Feb 23, 2026 | $0.08 | $0.03 | 166.7 % |
| Q3 | Nov 3, 2025 | $0.09 | $0.10 | -10.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $753.21M | $722.14M | 4.30 % |
| Q1 | May 11, 2026 | $608.10M | $617.41M | -1.51 % |
| Q4 | Feb 23, 2026 | $617.82M | $618.03M | -0.03 % |
| Q3 | Nov 3, 2025 | $598.98M | $581.38M | 3.03 % |